Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation.

Linares GR, Brommage R, Powell DR, Xing W, Chen ST, Alshbool FZ, Lau KH, Wergedal JE, Mohan S.

J Bone Miner Res. 2012 Jul;27(7):1553-65. doi: 10.1002/jbmr.1600.

2.

Disruption of claudin-18 diminishes ovariectomy-induced bone loss in mice.

Kim HY, Alarcon C, Pourteymour S, Wergedal JE, Mohan S.

Am J Physiol Endocrinol Metab. 2013 Mar 1;304(5):E531-7. doi: 10.1152/ajpendo.00408.2012. Epub 2013 Jan 8.

3.

Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.

Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N.

Endocrinology. 2001 Aug;142(8):3656-62.

PMID:
11459815
4.

Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.

Cheng S, Zhao SL, Nelson B, Kesavan C, Qin X, Wergedal J, Mohan S, Xing W.

PLoS One. 2012;7(3):e32887. doi: 10.1371/journal.pone.0032887. Epub 2012 Mar 5.

5.
6.

The generation of highly enriched osteoclast-lineage cell populations.

Quinn JM, Whitty GA, Byrne RJ, Gillespie MT, Hamilton JA.

Bone. 2002 Jan;30(1):164-70.

PMID:
11792580
7.

Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages.

Kim AR, Kim HS, Lee JM, Choi JH, Kim SN, Kim DK, Kim JH, Mun SH, Kim JW, Jeon HS, Kim YM, Choi WS.

Eur J Pharmacol. 2012 May 5;682(1-3):29-36. doi: 10.1016/j.ejphar.2012.02.026. Epub 2012 Feb 24.

PMID:
22387094
8.

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.

Valverde P, Tu Q, Chen J.

J Bone Miner Res. 2005 Sep;20(9):1669-79. Epub 2005 May 16.

9.
10.

Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.

Wang L, Zhao R, Shi X, Wei T, Halloran BP, Clark DJ, Jacobs CR, Kingery WS.

Bone. 2009 Aug;45(2):309-20. doi: 10.1016/j.bone.2009.04.203. Epub 2009 Apr 18.

11.

Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.

Shim KS, Ha H, Kim T, Lee CJ, Ma JY.

Am J Chin Med. 2015;43(5):1013-30.

PMID:
26205967
12.

Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.

Wang L, Shi X, Zhao R, Halloran BP, Clark DJ, Jacobs CR, Kingery WS.

Bone. 2010 May;46(5):1369-79. doi: 10.1016/j.bone.2009.11.029. Epub 2009 Dec 2.

13.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
14.

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T.

J Exp Med. 2000 Jan 17;191(2):275-86.

16.

Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism.

Remen KM, Henning P, Lerner UH, Gustafsson JÅ, Andersson G.

J Biol Chem. 2011 Sep 23;286(38):33084-94. doi: 10.1074/jbc.M111.235937. Epub 2011 Jul 22.

17.

Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.

Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.

J Cell Physiol. 2009 Dec;221(3):618-28. doi: 10.1002/jcp.21892.

PMID:
19653230
19.

Adenosine A(2A) receptor ligation inhibits osteoclast formation.

Mediero A, Kara FM, Wilder T, Cronstein BN.

Am J Pathol. 2012 Feb;180(2):775-86. doi: 10.1016/j.ajpath.2011.10.017. Epub 2011 Nov 30.

Supplemental Content

Support Center